Adult Relapsed Refractory B-cell Acute Lymphoblastic Leukemia: 2021 Updates

Recommendations for assessing and treating patients with relapsed/refractory B-cell ALL based on more recent data presented at ASH 2021.

February 22nd 2022

Closing thoughts on advances and future perspectives in the treatment of patients with relapsed/refractory B-cell acute lymphoblastic leukemia.